Menu

News & events

Keep up-to-date with the latest Synthetic Biology information from across the industry


Measurement for Recovery

Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...

Read article
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer

Macrophage Pharma Limited ("MPL"), a biotech company focused on the discovery and development of next-generation immunomodulatory small molecules indu...

Read article
The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course

The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...

Read article
Prokarium secures £4.6m Wellcome funding for Entervax

Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.Follow this link for ...

Read article
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards

London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at...

Read article
Evonetix makes key appointments to support development of novel gene synthesis technology

CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthes...

Read article
Global Biofoundry Meeting, London, June 2018

A meeting was held at Imperial College London on June 21st/22nd 2018, which gathered fifteen[1]of the leading synthetic biology biofoundries from around the world to discuss current activities and exchange information on key capabilities and projects being developed by these groups.

Read article
Save the date for our first Synthetic Biology Industrial Translation Showcase

The inaugural SynbiCITE – Synthetic Biology Industrial Translation Showcase will take place on Tuesday 5th June from 9.00am-5.00pm at the Royal Academy of Engineering

Read article
Synpromics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2017

SynbiCITE congratulates Synpromics as the winner of Best Emerging UK Synthetic Biotech Company at OBN’s 9th Annual Awards.

Read article
World leading DNA technology is expanding its operations in London as it grows to meet global DNA demand

Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial scale DNA in a two-week process – a...

Read article
Synpromics raises £5.2m of new investment

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.

Read article
Lab automation or robotic scientists: Dr McClymont and Professor Freemont share their views in Nature Biotechnology

Dr David McClymont, head of automation at the London DNA Foundry, and Professor Paul Freemont, Co-director of the London DNA Foundry and the EPSRC Cen...

Read article
SynbiTECH2020 is going virtual!

SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.

Read article
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food

An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...

Read article
Data-driven design and the opportunities it presents for biotech companies

Professor Paul Freemont, Co-Director of SynbiCITE, discussed the synthetic biology industry and the opportunities it is creating in a recently paper published in The Emerging Topics in Life Sciences entitled “Synthetic biology industry: data-driven design is creating new opportunities in biotechnology”.

Read article
Book before March 29th to receive 20% discount*

Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....

Read article
Addressing Global Challenges

Expert insights from SynbiCITE's leadership on the role of synthetic biology in solving some of the most significant challenges currently faced by our society

Read article
Buildings made from fungi? Meet London’s pop-up bio-lab innovators

If there’s one place you wouldn’t expect a new biotech research lab to be built, it’s slap bang in the middle of a busy London marketFind out more her...

Read article
SynbiCITE/Synbiobeta Webinar

If you missed the webinar you can catch up here https://synbiobeta.com/synbicite-webinarThe webinar highlighted findings from SynBioBeta’s 2018 Q2 inv...

Read article
Prokarium secures $10 million investment

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccinesKeele...

Read article
Breathing chandeliers and algae sculptures: bionic art comes to the V&A

Arborea, based in Imperial College’s White City innovation hub, has been featured in the Financial Times.

Read article
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...

Read article
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology

A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.

Read article
Touchlight welcomes Dr. Geoff Smith

Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.

Read article
East African Collaborations in Practical Synthetic Biology Workshop

From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking plac...

Read article
Evonetix raises $30 million USD (£23 million GBP)

Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...

Read article
SynbiTECH2020 - Sponsor or Exhibit?

Happy new year! 2020 is the start of a new decade in which synthetic biology will thrive and grow – by 2030 we expect the global marketplace to be at ...

Read article
The Cell Factories of the Future

Professor Paul Freemont, Co-Director of SynbiCITE, is the lead author of a recent article published by the World Economic Forum on this subject, entitled “How scientists are turning living cells into the tiny factories of the future”.

Read article
Evonetix establishes scientific advisory board

CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...

Read article
Synthace launches ground-breaking new whitepaper

Comprehensive report heralds the beginning of Computer Aided Biology (CAB)LONDON October 01 2018 - Synthace Ltd., the company behind the leading cloud...

Read article
A Lloyd's Emerging Risk Report

Synthetic biology, the application of engineering principles to genetic modification is a market forecast to grow to $39bn by 2020. In recent years sc...

Read article
RebelBio | Ready to change the world with biology?

RebelBio, the world’s first early-stage life-sciences accelerator, has opened their applications for the Winter Programme. Science graduates, PhDs, po...

Read article
Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem

CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...

Read article
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology, Metrology and Standards

NPL, the UK's National Measurement Institute (NMI), and SynbiCITE at Imperial College London, have announced the establishment of a new £7 million virtual lab to underpin their joint Centre for Engineering Biology, Metrology and Standards to help the UK synthetic biology industry improve the manufacturing and adoption of new products - in partnership with LGC and NIBSC.

Read article
Synpromics expands facilities to meet demand for revolutionary gene control technology

Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre.

Read article
CustoMem wins £100K 1st Prize in Bio-start competition

SynbiCITE and Rainbow Seed Fund congratulate CustoMem as winners of the 1st Prize in the Bio-start competition for companies using engineering biology to solve significant global problems.

Read article
Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition

Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol.

Read article
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform

CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...

Read article
Kick off 2020 with a bang!

Don't miss our SUPER EARLY BIRD offer, ending 31st January! "Pretty much everyone we were looking to connect with in the synthetic biology and indust...

Read article
SynbiTECH 2020 - Register your interest

SynbiTECH will return on the 26-27th October 2020!To be kept up to date on ticket sales and conference announcements please register your interest her...

Read article
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution

Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...

Read article
SynbiCITE launches new five-year strategy

SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, launches a new five-year strategy underpinned by a new £5M grant from UKRI and other sources.

Read article
New competition - metasurfaces for defence and security

This themed competition is seeking proposals for innovative solutions that will pull ideas from recent breakthroughs in metasurface science into produ...

Read article
SynbiCITE House of Lords Investor Breakfast

The SynbiCITE House of Lords Investor Breakfast was kindly hosted by The Lord Willetts - who instigated the Government’s ‘8 Great Technologies’ progra...

Read article
SynbiCITE welcomes RebelBio to London

We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itse...

Read article
£17 million boost to the UK’s leading life sciences sector

The Chancellor of the Exchequer, Philip Hammond, announced this week £17million new funding will be supplied for UK life science, helping to create real benefits for the NHS and patients.

Read article
Three upcoming Innovation Funding competitions through InnovateUK

​InnovateUK, the UK’s innovation agency, has three forthcoming Innovation Funding Competitions that opened recently.

Read article
UK Synthetic Biology Start up Survey 2017

We would like to invite you to the Breakfast Seminar Launch of SynbiCITE’s UK Synthetic Biology Start-up Survey on Friday 21st July 2017, at 9.00-10:4...

Read article
Scientists engineer baker's yeast to produce penicillin molecules

The synthetic biologists from Imperial College London have re-engineered yeast cells to manufacture the nonribosomal peptide antibiotic penicillin. In laboratory experiments, they were able to demonstrate that this yeast had antibacterial properties against streptococcus bacteria.

Read article